Skip to content

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery

Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00517452
Acronym
PRP
Enrollment
81
Registered
2007-08-17
Start date
2007-05-31
Completion date
2007-12-31
Last updated
2011-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Brief summary

The use of platelet rich plasma will decrease wound infection postop.

Interventions

None listed

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision

Exclusion criteria

Patients requiring emergent procedures, unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Wound healing4- 6 weeks post op

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026